# OnCo record psma-prerp (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/psma-prerp/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "psma-prerp", "NCT03368547" ;
  schema:name "PSMA-PreRP"@en ;
  schema:alternateName "68Ga-PSMA-11 PET before radical prostatectomy"@en, "16-001684"@en ;
  schema:description "The UCLA and UCSF scan study behind the first US approval of gallium PSMA PET: in men heading for prostate surgery it was very reliable when it called a pelvic lymph node positive, but it still missed about three in five of the nodes that pathology later found."@en ;
  schema:url <https://onco.cc/trials/psma-prerp/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03368547>, <https://clinicaltrials.gov/study/NCT02919111>, <https://clinicaltrials.gov/study/NCT02611882>, <https://doi.org/10.1001/jamaoncol.2021.3771>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4643b31-9b4f-673f-e053-2a95a90a559d> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/psma-pet/>, <https://onco.cc/technologies/pet-ct/> ;
  onco:targets <https://onco.cc/targets/psma/> ;
  onco:drugs <https://onco.cc/drugs/illuccix/>, <https://onco.cc/drugs/ga68-psma-11/> ;
  onco:institutions <https://onco.cc/institutions/ucla-jonsson/>, <https://onco.cc/institutions/ucsf/> ;
  onco:terms <https://onco.cc/terms/sensitivity-specificity/>, <https://onco.cc/terms/ppv/> ;
  onco:people <https://onco.cc/people/thomas-hope/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-psma-prerp-hope-jama-oncol-2021/> .